![](/img/cover-not-exists.png)
More evidence for dolutegravir as first-line ART for all
Estill, Janne, Bertisch, BarbaraLanguage:
english
Journal:
The Lancet HIV
DOI:
10.1016/S2352-3018(19)30414-X
Date:
February, 2020
File:
PDF, 42 KB
english, 2020